Nanomaterials for Cancer Therapy and Imaging

다국어 초록 (Multilingual Abstract)

A variety of organic and inorganic nanomaterials with dimensions below several hundred nanometers are recently emerging as promising tools for cancer therapeutic and diagnostic applications due to their unique characteristics of passive tumor targeting. A wide range of nanomedicine platforms such as polymeric micelles, liposomes, dendrimers,and polymeric nanoparticles have been extensively explored for targeted delivery of anti-cancer agents,because they can accumulate in the solid tumor site via leaky tumor vascular structures, thereby selectively delivering therapeutic payloads into the desired tumor tissue.
In recent years, nanoscale delivery vehicles for small interfering RNA (siRNA) have been also developed as effective therapeutic approaches to treat cancer. Furthermore, rationally designed multi-functional surface modification of these nanomaterials with cancer targeting moieties, protective polymers, and imaging agents can lead to fabrication versatile theragnostic nanosystems that allow simultaneous cancer therapy and diagnosis. This review highlights the current state and future prospects of diverse biomedical nanomaterials for cancer therapy and imaging.

참고문헌 (Reference)

1 Oh, Y., "siRNA delivery systems for cancer treatment" ELSEVIER SCIENCE BV 61 : 850-862, 2009

2 Denekamp, J., "Vasculature as a target for tumour therapy" 4 : 28-38, 1984

3 Yuan, F., "Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size" 55 : 3752-3756, 1995

4 Dvorak, H.F., "Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis" 146 : 1029-1039, 1995

5 Park, J., "Ultra-large-scale syntheses of monodisperse nanocrystals" NATURE PUBLISHING GROUP 3 (3): 891-895, 2004

6 Bergers, G., "Tumorigenesis and the angiogenic switch" 3 : 401-410, 2003

7 Maeda, H., "Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects" 21 : 797-802, 2010

8 Campbell, R.B., "Tumor physiology and delivery of nanopharmaceuticals" 6 : 503-512, 2006

9 Senger, D.R., "Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid" 219 : 983-985, 1983

10 Folkman, J., "Tumor angiogenesis" 19 : 331-358, 1974

11 Lee, S.H., "Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock" 125 : 25-35, 2008

12 Wagner, V., "The emerging nanomedicine landscape" 24 : 1211-1217, 2006

13 Duncan, R., "The dawning era of polymer therapeutics" 2 : 347-360, 2003

14 Lee, A.L.Z., "The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles" 30 : 919-927, 2009

15 Ferrara, N., "The biology of vascular endothelial growth factor" 18 : 4-25, 1997

16 Hong, S., "The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform" 14 : 107-115, 2007

17 Isaiah J. Fidler, "The Brain Microenvironment and Cancer Metastasis" 한국분자세포생물학회 30 (30): 93-98, 2010

18 Lenhard Rudolph, "Telomeres and Telomerase in Aging, Regeneration and Cancer" 한국분자세포생물학회 15 (15): 164-175, 2003

19 Kang, H., "Tatconjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides" 22 : 2099-2106, 2005

20 Lee, H., "Targetspecific intracellular delivery of siRNA using degradable hyaluronic acid nanogels" 119 : 245-252, 2007

21 Derfus, A.M., "Targeted quantum dot conjugates for siRNA delivery" 18 : 1391-1396, 2007

22 Gupta, A.K., "Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications" 26 : 3995-4021, 2005

23 Kim, H.K., "Surface stabilization of diblock PEG-PLGA micelles by polymerization of N-vinyl-2-pyrrolidone" 23 : 26-31, 2002

24 "Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging" Elsevier BV 32 (32): 176-184, 2011

25 Bolcato-Bellemin, A., "Sticky overhangs enhance siRNA-mediated gene silencing" 104 : 16050-16055, 2007

26 Yi, S.W., "Stable lipiodolized emulsions for hepatoma targeting and treatment by transcatheter arterial chemoembolization" 50 : 135-143, 1998

27 Lee, S., "Stability and cellular uptake of polymerized siRNA (poly-siRNA)/polyethylenimine (PEI) complexes for efficient gene silencing" ELSEVIER SCIENCE BV 141 (141): 339-346, 2010

28 Ruoslahti, E., "Specialization of tumour vasculature" 2 : 83-90, 2002

29 Mok, H., "Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA" JOHN WILEY & SONS INC 89 : 881-888, 2008

30 "Reducible siRNA Dimeric Conjugates for Efficient Cellular Uptake and Gene Silencing" AMER CHEMICAL SOC 22 (22): 299-306, 2011

31 Torchilin, V.P., "Recent advances with liposomes as pharmaceutical carriers" 4 : 145-160, 2005

32 Yezhelyev, M.V., "Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging" 130 : 9006-9012, 2008

33 Höbel, S., "Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab" 12 : 287-300, 2010

34 Bartlett, D.W., "Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles" 18 : 456-468, 2007

35 Lee, H., "Perspectives on: local and sustained delivery of angiogenic growth factors" 22 : 89-114, 2007

36 Spencer, C.M., "Paclitaxel:a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer" 48 : 794-847, 1994

37 Mok, H., "PEGylated and MMP-2 Specifically DePEGylated Quantum Dots: Comparative Evaluation of Cellular Uptake" AMER CHEMICAL SOC 25 : 1645-1650, 2009

38 Kim, S.H., "PEG conjugated VEGF siRNA for anti-angiogenic gene therapy" 116 : 123-129, 2006

39 Park, J., "Onenanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles" 44 : 2872-2877, 2005

40 Bae, K.H., "Oil-encapsulating PEO PPO-PEO/PEG shell cross-linked nanocapsules for targetspecific delivery of paclitaxel" 8 : 650-656, 2007

41 Couvreur, P., "Nanotechnology: Intelligent design to treat complex disease" 23 : 1417-1450, 2006

42 Nie, S., "Nanotechnology applications in cancer" 9 : 257-288, 2007

43 Heath, J.R., "Nanotechnology and cancer" 59 : 251-265, 2008

44 Goldberg, M., "Nanostructured materials for applications in drug delivery and tissue engineering" 18 : 241-268, 2007

45 Hirsch, L.R., "Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance" 100 : 13549-13554, 2003

46 Rivera Gil, P., "Nanopharmacy: inorganic nanoscale devices as vectors and active compounds" 62 : 115-125, 2010

47 Davis, M.E., "Nanoparticle therapeutics: an emerging treatment modality for cancer" 7 : 771-782, 2008

48 Peer, D., "Nanocarriers as an emerging platform for cancer therapy" 2 : 751-760, 2007

49 Montet, X., "Multivalent effects of RGD peptides obtained by nanoparticle display" 49 : 6087-6093, 2006

50 Mok, H., "Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing" NATURE PUBLISHING GROUP 9 (9): 272-278, 2010

51 Salvador-Morales, C., "Multifunctional nanoparticles for prostate cancer therapy" 9 : 211-221, 2009

52 McCarthy, J.R., "Multifunctional magnetic nanoparticles for targeted imaging and therapy" 60 : 1241-1251, 2008

53 Meister, G., "Mechanisms of gene silencing by double-stranded RNA" 43 : 343-349, 2004

54 Kim, S.H., "Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer" 129 : 107-116, 2008

55 Schroeder, A., "Lipid-based nanotherapeutics for siRNA delivery" 267 : 9-21, 2009

56 Chen, H., "Lecting-bearing polymerized liposomes as potential oral vaccine carriers" 13 : 1378-1383, 1996

57 Dykxhoorn, D.M., "Knocking down disease with siRNAs" 126 : 231-235, 2006

58 Whitehead, K.A., "Knocking down barriers: advances in siRNA delivery" 8 : 129-138, 2009

59 de Fougerolles, A., "Interfering with disease: a progress report on siRNAbased therapeutics" 6 : 443-453, 2007

60 Mao, S., "Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylenimine)-graft-poly(ethylene glycol) block copolymer/siRNA polyplexes" 17 : 1209-1218, 2006

61 Roberts, W.G., "Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor" 108 : 2369-2379, 1995

62 Ran, S., "Increased exposure of anionic phospholipids on the surface of tumor blood vessels" 62 : 6132-6140, 2002

63 Gao, X., "In vivo cancer targeting and imaging with semiconductor quantum dots" 22 : 969-976, 2004

64 Yoo, H.S., "In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates" 68 : 419-431, 2000

65 Lee, K, "Hyaluronic acid-paclitaxel conjugate micelles: Synthesis, characterization, and antitumor activity" AMER CHEMICAL SOC 19 (19): 1319-1325, 2008

66 Dobson, J., "Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery" 13 : 283-287, 2006

67 Jung, S., "Gene silencing efficiency of siRNA-PEG conjugates: Effect of PEGylation site and PEG molecular weight" ELSEVIER SCIENCE BV 144 : 306-313, 2010

68 Akinc, A., "Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis" 7 : 657-663, 2005

69 Hubbell, J.A., "Enhancing drug function" 300 : 595-596, 2003

70 Juliano, R.L., "Effect of particle size and charge on the clearance rates of liposomes and liposome-encapsulated drugs" 63 : 651-658, 1975

71 Kohandel, M., "Dynamics of tumor growth and combination of antiangiogenic and cytotoxic therapies" 52 : 3665-3677, 2007

72 Elbashir, S.M., "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells" 411 : 494-498, 2001

73 Allen, T.M., "Drug delivery systems:entering the mainstream" 303 : 1818-1822, 2004

74 Reischl, D., "Drug delivery of siRNA therapeutics:potentials and limits of nanosystems" 5 : 8-20, 2009

75 Miao, G., "Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells" 13 : 1170-1174, 2007

76 Burt, H.M., "Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel" 16 : 161-171, 1999

77 Kim, J., "Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery" 20 : 478-483, 2008

78 Jain, R.K., "Delivery of molecular and cellular medicine to solid tumors" 46 : 149-168, 2001

79 Park, T.G., "Current status of polymeric gene delivery systems" 58 : 467-486, 2006

80 Park, J.H., "Cooperative nanomaterial system to sensitize, target, and treat tumors" 107 : 981-986, 2009

81 Kim, S.H., "Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI−PEG−FOL conjugate" 17 : 241-244, 2006

82 Potter, R.F., "Capillary diameter and geometry in cardiac and skeletal muscle studied by means of corrosion casts" 25 : 68-84, 1983

83 Ferrari, M., "Cancer nanotechnology: opportunities and challenges" 5 : 161-171, 2005

84 Meyer, M., "Breathing life into polycations: functionalization with pHresponsive endosomolytic peptides and polyethylene glycol enables siRNA delivery" 130 : 3272-3273, 2008

85 Kataoka, K., "Block copolymer micelles for drug delivery: design, characterization and biological significance" 47 : 113-131, 2001

86 Kim, Y.B, "Bioinspired Surface Immobilization of Hyaluronic Acid on Monodisperse Magnetite Nanocrystals for Targeted Cancer Imaging" WILEY-V C H VERLAG GMBH 20 (20): 4154-4154, 2008

87 Tang, A., "Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes" 20 : 360-367, 2003

88 Holle, L., "Bcl-2 targeting siRNA expressed by a T7 vector system inhibits human tumor cell growth in vitro" 24 : 615-621, 2004

89 Carmeliet, P., "Angiogenesis in cancer and other diseases" 407 : 249-257, 2000

90 Lee, J., "All-in-one target cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery" 48 : 4174-4179, 2009

91 Dalby, B., "Advanced transfection with Lipofectamine 2000 reagent:primary neurons,siRNA,and highthroughput applications" 33 : 95-103, 2004

92 Klibanov, A.L., "Activity of amphipathic PEG 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavourable for immunoliposome binding to target" 1062 : 142-148, 1991

93 Morikawa, S., "Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors" 160 : 985-1000, 2002

94 Matsumura, Y., "A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs" 46 : 6387-6392, 1986